By comparing our GBP2 expression profiles with a published melanoma immunotherapy dataset,33 the results showed that high GBP2 group were highly similar to the PD-1-response group in the six cohorts (figure 7C and online supplemental figure S15). This evidence concerns the gene GBP2 and melanoma.